Have you gone out and left the television on? Have you ever forgot to buy the item for which you went shopping for? These are examples of prospective memory failure, which could be an early sign of Alzheimer's disease.
Glaucoma is an eye disorder causing irreversible blindness and affects around 60 million people throughout the world. This condition leads to the loss of retinal ganglion cells, located near the surface of the retina. The prime focus of glaucoma research is to put an end to the loss of these cells in the initial stages.
If a drop of blood is seen in stool, people tend to panic. The causative factors could include digestive, respiratory, circulatory, hematological or even neuropsychological diseases.
A research team from Tel Aviv University suggested that red wine and green tea could treat certain congenital metabolic diseases, by blocking toxic metabolite formations. Since people with inborn metabolic disorders are born with a defective gene, it leads to a critical enzyme deficiency. Since there is no cure, many patients with congenital metabolic disorders are required to follow a lifelong strict diet.
The subscription-based consumer-friendly service named Brain U Online provides cognitive tasks with exercise to delay the progression of dementia by 2.5 years and reduce its negative effect by 45%.
The DDF initially aimed to raise £130 million with committed investments from GlaxoSmithKline, Biogen, Eli Lilly, Pfizer and Takeda, Johnson & Johnson, as well as the U.K. government’s Department of Health and the nonprofit Alzheimer’s Research UK.
A new robotic system called OSCANN Desk has been developed by researchers at Spain’s Universidad Politécnica de Madrid (UPM) and start-up AURA Innotive Robotics. The system has been designed for the accurate analysis of eye movements in order to detect neurodegenerative diseases such as Parkinson’s disease.
Anti-aging studies are still going on worldwide, in spite of having lots of good and bad consequences. During the 1950’s, scientists proved that the organs of older mice became healthier, by injecting them with younger blood. The scientists also found that aging was connected to only body and it’s ultimately the blood which directs aging.
IDx, a privately held AI diagnostics company, announced today that it has filed its De Novo submission to the FDA for IDx-DR, an AI-based system for the autonomous detection of diabetic retinopathy — a leading cause of blindness. The FDA has granted IDx-DR with a “Breakthrough Device” designation, which means the submission will receive expedited review.
Health technology and clinical wearables are hot topics in the healthcare and pharmaceutical industries. They are creating waves of excitement and talking points for debate, while also topping many of the healthcare trends of this year.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.